BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Li CD, Sun L. Recent Advances in Molecular Mechanisms of the NKG2D Pathway in Hepatocellular Carcinoma. Biomolecules 2020;10:E301. [PMID: 32075046 DOI: 10.3390/biom10020301] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Cao W, Zhang Y, Li A, Yu P, Song L, Liang J, Cao N, Gao J, Xu R, Ma Y, Tang X. Curcumin reverses hepatic epithelial mesenchymal transition induced by trichloroethylene by inhibiting IL-6R/STAT3. Toxicol Mech Methods 2021;:1-11. [PMID: 34233590 DOI: 10.1080/15376516.2021.1941463] [Reference Citation Analysis]
2 Hammad R, Eldosoky MA, Mosaad AM, El-Nasser AM, Kotb FM, Elshennawy SI, Eldesoky NA, Selim MA, Naguib GG, Ahmed OA, Alboraie M, Aglan RB. Natural Killer Group 2D Receptor and B1a Cells Crosstalk in Post-Hepatitis C Virus Infection Hepatocellular Carcinoma and Cirrhosis. J Hepatocell Carcinoma 2022;9:609-19. [PMID: 35879974 DOI: 10.2147/JHC.S360886] [Reference Citation Analysis]
3 Fu R, Yu F, Wu W, Liu J, Li J, Guo F, Xu L, Wang F, Cui X. Bufalin enhances the killing efficacy of NK cells against hepatocellular carcinoma by inhibiting MICA shedding. Int Immunopharmacol 2021;101:108195. [PMID: 34678691 DOI: 10.1016/j.intimp.2021.108195] [Reference Citation Analysis]
4 Gorvel L, Olive D. Targeting the "PVR-TIGIT axis" with immune checkpoint therapies. F1000Res 2020;9:F1000 Faculty Rev-354. [PMID: 32489646 DOI: 10.12688/f1000research.22877.1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 8.5] [Reference Citation Analysis]
5 Xia C, Liu C, He Z, Cai Y, Chen J. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression. J Exp Clin Cancer Res 2020;39:127. [PMID: 32631421 DOI: 10.1186/s13046-020-01627-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
6 Siemaszko J, Marzec-Przyszlak A, Bogunia-Kubik K. NKG2D Natural Killer Cell Receptor-A Short Description and Potential Clinical Applications. Cells 2021;10:1420. [PMID: 34200375 DOI: 10.3390/cells10061420] [Reference Citation Analysis]